Topalind 0.5 % cream is a non-prescription medicine containing the active ingredient: hydrocortisone. For short-term external use in moderate inflammatory and allergic skin conditions.
€9.90*
Prices incl. VAT plus shipping costs (Kann sich je nach Land ändern)
⁴
Topalind 0.5 % cream is a non-prescription medicine containing the active ingredient: hydrocortisone. For short-term external use in moderate inflammatory and allergic skin diseases.
Topalind is a medicinal product with a low concentration of a weakly active corticosteroid, which is used for the short-term (maximum 2 weeks) external treatment of moderate inflammatory and allergic skin diseases.
The active ingredient hydrocortisone has a mild anti-inflammatory effect.
Topalind is used for the treatment of moderately red, inflamed or allergic skin conditions in adults, adolescents and children over 6 years of age for which mildly effective corticosteroids in low concentrations are indicated.
If you do not feel better or even worse after two weeks, consult your doctor.
Dosage form
cream
Directions for use
- Adults, adolescents and children over 6 years of age: Apply a thin layer of Topalind to the affected areas two to three times a day and rub in gently. Once the condition has improved, Topalind should usually only be applied once a day or every 2nd or 3rd day. Even after the symptoms have subsided, Topalind should continue to be applied for a few days to prevent the disease from flaring up again.
- Use in children under 6 years of age: You may only treat your child with Topalind if the doctor has prescribed Topalind for the child.
- Method of application: Topalind is applied to the skin in a thin layer and gently rubbed in. When applying to the face, care must be taken to ensure that Topalind does not get into the eyes.
- Duration of treatment: Topalind is intended for short-term application to the skin (max. 2 weeks) in adults, adolescents and children aged 6 years and over. The duration of treatment depends on the success of the therapy and should be continued for a few days after the symptoms have subsided in order to prevent the disease from flaring up again. Treatment lasting longer than two weeks may only be carried out under medical supervision. The duration of treatment for children should be kept to a minimum. Please talk to your doctor or pharmacist if you have the impression that the effect of Topalind is too strong or too weak.
Ingredients
- What Topalind contains - The active ingredient is: hydrocortisone. 1 g cream contains 5 mg hydrocortisone.
- The other ingredients are: stearic acid, propylene glycol, sorbitan stearate, polysorbate 60, octyldodecanol, hard fat, purified water.
| Gramm: | 15 |
|---|
Anwendungshinweise
| Art der Anwendung: | LogImport.sisx.AAD.Auf die betroffenen Hautstellen dünn auftragen |
|---|---|
| Anwendungsgebiet: | LogImport.sisx.AGD.Kortikoidtherapie von erythematösen, entzündlichen oder allergischen Hauterkrankungen mit mittlerer Symptomausprägung |
| Dosierung: | LogImport.sisx.DOD.Personen ab 6 Jahren 2-3 mal tgl auftragen, bei Besserung auf 1 mal tgl oder alle 2-3 Tage reduzieren Ohne ärztliche Anordnung max 2 Wochen anwenden, danach mind 1 Woche pausieren Bei Anwendung von 10 KOF max 1 Woche anwenden Bei Ki |
| Eigenschaften und Wirksamkeit: | LogImport.sisx.EWD.Topisches Kortikosteroid immunsuppressiv |
| Gegenanzeigen: | LogImport.sisx.GAD.Syphilis oder Tuberkulose der Haut, Herpes simplex, Gürtelrose, Windpocken, Impfreaktionen, Rosazea, AkneSteroidakne, periorale Dermatitis, offene Wunden, Augenbereich |
| Nebenwirkungen: | LogImport.sisx.NWD.Leichtes Brennen, allergische Reaktionen Bei Langzeitanwendung systemische Efekte möglich Sehstörungen, Hautatrophie, NNR-Suppression |
| Besondere Warnhinweise zur sicheren Anwendung: | LogImport.sisx.WHD.Infektionen der Haut gesondert behandeln Vorsicht mit Okklusivverbänden, bei Kleinkindern nicht im Windelbereich anwenden Bei längerer Anwendung auf Sehstörungen achten |
| Wechselwirkungen: | LogImport.sisx.WWD.Keine bekannt |
| Schwangerschaft und Stillperiode: | LogImport.sisx.SSTD.Topische Anwendung kortikoidhaltiger Zubereitungen im 1 Trimenon vermeiden, danach NutzenRisiko-Abwägung In der Stillzeit kleinflächige, kurze Anwendung möglich nicht im Brustbereich! |
Schwangerschaftshinweise
| Anwendung verboten |
|---|
| Anwendung nur bei zwingender oder vitaler Indikation |
Stillzeithinweise
| Stillen unter sorgfältiger Kontrolle möglich |
|---|